Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Livtencity Generic Name & Formulations
Legal Class
Rx
General Description
Maribavir 200mg; tabs.
Pharmacological Class
CMV pUL97 kinase inhibitor.
How Supplied
Tabs—28, 56
Manufacturer
Generic Availability
NO
Livtencity Indications
Indications
Post-transplant cytomegalovirus (CMV) infection/disease that is refractory to treatment (with or without genotypic resistance) with ganciclovir, valganciclovir, cidofovir or foscarnet.
Livtencity Dosage and Administration
Adults and Children
<12yrs: not established. Tabs can be swallowed whole, dispersed or crushed (prepared in susp form); or as dispersed tabs (prepared in susp form) through a nasogastric or orogastric tube; see full labeling. ≥12yrs (≥35kg): 400mg twice daily. Concomitant carbamazepine: increase to 800mg twice daily. Concomitant phenytoin or phenobarbital: increase to 1200mg twice daily.
Livtencity Contraindications
Not Applicable
Livtencity Boxed Warnings
Not Applicable
Livtencity Warnings/Precautions
Warnings/Precautions
Virologic failure during treatment or relapse during posttreatment (within 4–8 weeks) after discontinuation may occur. Monitor CMV DNA levels and check for resistance if relapses or no treatment response. ESRD including dialysis, severe hepatic impairment: not studied. Pregnancy. Nursing mothers.
Livtencity Pharmacokinetics
See Literature
Livtencity Interactions
Interactions
Concomitant ganciclovir, valganciclovir, CYP3A4 strong inducers (except for certain anticonvulsants; see Adults and Children): not recommended. Antagonized by rifabutin, rifampin, St. John’s wort: avoid concomitant use. May potentiate immunosuppressant drugs that are CYP3A and/or P-gp substrates (eg, tacrolimus, cyclosporine, sirolimus, everolimus); monitor levels frequently and adjust dose of substrate as needed. Caution with digoxin; monitor levels; may need to reduce digoxin dose. Potentiates rosuvastatin; monitor closely for myopathy and rhabdomyolysis.
Livtencity Adverse Reactions
Adverse Reactions
Taste disturbance, nausea, diarrhea, vomiting, fatigue.
Livtencity Clinical Trials
See Literature
Livtencity Note
Not Applicable
Livtencity Patient Counseling
See Literature
